Verona Pharma

NASDAQ: VRNA · Real-Time Price · USD
105.28
0.01 (0.01%)
At close: Aug 15, 2025, 12:48 PM

Verona Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-173.42M -54.58M -68.7M -55.57M
Depreciation & Amortization
1.06M 116K 636K 629K
Stock-Based Compensation
41.24M 19.01M 14.12M 25.43M
Other Working Capital
26.11M -14.44M -3.59M 3.58M
Other Non-Cash Items
14.65M -332.39K 4.82M 239K
Deferred Income Tax
n/a -486K n/a -17.42M
Change in Working Capital
-5.74M -13.95M -10.74M 13.44M
Operating Cash Flow
-122.2M -50.22M -59.86M -33.25M
Capital Expenditures
n/a 4.07 -29K -12K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-580K n/a -29K -12K
Investing Cash Flow
-580K n/a -29K -12K
Debt Repayment
70.24M 38.71M 5M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
83.04M -2.75M -13.98M -6.85M
Financial Cash Flow
250.78M 92.87M 140.82M -6.12M
Net Cash Flow
127.98M 43.95M 79.45M -39.61M
Free Cash Flow
-122.78M -50.22M -59.89M -33.27M